| Accession |
PRJCA017061 |
| Title |
Safety, tolerability and pharmacokinetics of HS-10366 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase 1 trial |
| Relevance |
Medical |
| Data types |
pharmacokinetic data
|
| Organisms |
Homo sapiens
|
| Description |
The study aimed to evaluate the safety, tolerability and pharmacokinetic characteristics of oral HS-10366 in healthy Chinese adults. |
| Sample scope |
human blood sample from multiple subjects |
| Release date |
2023-05-17 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Hansoh Pharmceutical Co. Ltd
|
|
N/A
|
|
|
|
| Submitter |
Benjie
Wang (wangbenjie7636@126.com)
|
| Organization |
Qilu Hospital of Shandong University |
| Submission date |
2023-05-17 |
